Elanco Animal Health, Inc. (ELAN)
23.97
+0.28
(+1.18%)
USD |
NYSE |
May 28, 16:00
23.78
-0.19
(-0.79%)
After-Hours: 19:11
Elanco Animal Health Research and Development Expense (Annual) : 368.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Zoetis, Inc. | 698.00M |
| Eli Lilly & Co. | 13.34B |
| Arvinas, Inc. | 282.90M |
| Corcept Therapeutics, Inc. | 254.91M |
| Assertio Holdings, Inc. | 1.69M |